The Enterprise Value as of December 2025 (TTM) for Genetic Signatures Limited (GSS.AX) is 52.37M

According to Genetic Signatures Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 52.37M. This represents a change of -39.19% compared to the average of 86.13M of the last 4 quarters.

Genetic Signatures Limited (GSS.AX) Historical Enterprise Value (quarterly & annually)

How has GSS.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Genetic Signatures Limited over the last ten years is 92.84M. The current 52.37M Enterprise Value has changed 5.54% with respect to the historical average. Over the past ten years (40 quarters), GSS.AX's Enterprise Value was at its highest in in the June 2020 quarter at 276.17M. The Enterprise Value was at its lowest in in the December 2012 quarter at 0.

Genetic Signatures Limited (GSS.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genetic Signatures Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genetic Signatures Limited (GSS.AX) Average Enterprise Value

How has GSS.AX Enterprise Value performed in the past?

The current Enterprise Value of Genetic Signatures Limited (GSS.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genetic Signatures Limited (GSS.AX) Enterprise Value vs. Peers

How is GSS.AX’s Enterprise Value compared to its peers?

Genetic Signatures Limited’s Enterprise Value is less than Cyclopharm Limited (104.48M), less than ImpediMed Limited (67.69M), greater than Cryosite Limited (52.36M), greater than Amplia Therapeutics Limited (52.00M), less than Mach7 Technologies Limited (108.46M), less than Beamtree Holdings Limited (59.51M), less than Compumedics Limited (86.12M), greater than Medical Developments International Limited (43.30M), less than Cynata Therapeutics Limited (57.88M), less than Micro-X Limited (61.39M),

Build a custom stock screener for Genetic Signatures Limited (GSS.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Signatures Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetic Signatures Limited (GSS.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetic Signatures Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.